GPRASP1 and breast cancer: We also investigated aberrant alterations of GASP1 in 1084 breast cancers from the cBioPortal database and found 0.09% genomic amplification (1/1084), 0.37% truncating mutations (4/1084), 0.74% missense mutations (8/1084), and 3.7% high mRNA expression (40/1084) (Fig. 1d).